|

DNP007 Clinical Trials

1 actively recruiting trial

Also known as: MD3, Anti-ICAM1

Pipeline

Phase 1: 1

Top Sponsors

  • Seoul National University Hospital1

Indications

  • Steatohepatitis, Nonalcoholic1
  • Liver Disease1
  • Liver Transplant Rejection1
  • Liver Transplant; Complications1

Other1 trial

Safety of DNP007 in Healthy Subjects
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.